GSK Investigational Site

Heidelberg, Victoria 3084

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Heidelberg,
Click here to add this to my saved trials
Oncology Clinical Trial
Dose Escalation and Expansion Study of GSK3359609 in Subjects With Selected Advanced Solid Tumors (INDUCE-1)
Status: Enrolling, Phase I
Updated: 12/31/1969
GSK Investigational Site
mi
from
Heidelberg,
Click here to add this to my saved trials